Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
117 hedge funds and large institutions have $132M invested in Ventyx Biosciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 37 reducing their positions, and 29 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 37
7% less funds holding
Funds holding: 126 → 117 (-9)
18.37% less ownership
Funds ownership: 99.58% → 81.21% (-18%)
25% less call options, than puts
Call options by funds: $670K | Put options by funds: $896K
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
59% less capital invested
Capital invested by funds: $324M → $132M (-$192M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$12M |
| 2 |
DM
Deerfield Management
New York
|
+$9.5M |
| 3 |
VPC
Vestal Point Capital
New York
|
+$5.46M |
| 4 |
BlackRock
New York
|
+$4.26M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$14.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.9M |
| 3 |
O
OrbiMed
New York
|
-$10.3M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.96M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$5.04M |
VTYX Hedge Fund Activity: Q2 2024 in Review
117 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2024, worth a combined $132M — down 59% from $324M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of VTYX and 21 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 37 added.
The largest buyer was Capital International Investors, adding an estimated $12M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $14.9M sold.
- 117 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2024, down from 126 in Q1 2024.
- Funds reported $132M of Ventyx Biosciences stock for Q2 2024, down 59% quarter-over-quarter.
- 21 funds opened new Ventyx Biosciences positions in Q2 2024 and 29 closed out, a net change of -8 holders.
- The largest Ventyx Biosciences buyer in Q2 2024 was Capital International Investors, an estimated $12M added.
- The largest Ventyx Biosciences seller in Q2 2024 was Cormorant Asset Management, an estimated $14.9M sold.
Based on aggregated 13F filings for Q2 2024.